Multiple cancers can be treated with tyrosine kinase inhibitors, which block proteins that aid cancer growth.
In most cases, MEK inhibitors are combined with BRAF inhibitors, such as Dabrafenib, Encorafenib, and Vemurafenib-Block B-Raf, to stop cell growth.
It targets the KRAS G12C and is the first approved treatment for any KRAS mutation in NSCLC.
Monoclonal antibodies, produced in the laboratory and resembling immune system defenses, treat various tumor types.
The immune response drug forms convey chemotherapy to the growths and treat tumors like those of the bosom and lymphoma.
With herbs like Amalaki, Rasayana Ayurveda detoxifies, boosts immunity, and balances the body's energy; this may prevent cancer mutations.